Clinical Trials Directory

Trials / Completed

CompletedNCT02619409

Evaluation of the Duration of Bupivacaine Spinal Block in Orthopedic Procedures With and Without Epinephrine Wash

Evaluation of the Duration of Bupivacaine Spinal Block as the Primary Anesthetic for Orthopedic Procedures With and Without Epinephrine Wash

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Bupivacaine spinal is commonly performed as the primary anesthetic for orthopedic procedures. In some cases the duration of the block is inadequate. An epinephrine wash is sometimes performed to prolong the duration of the block. The epinephrine wash may prolong the duration of the block, and if it does, to what extent?

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine OnlyThe bupivacaine only group will receive bupivacaine 0.5% 3cc plus sterile saline 0.1cc.
DRUGEPI25The EPI25 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.025cc, and sterile saline 0.075cc.
DRUGEPI50 groupThe EPI50 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.05cc, and sterile saline 0.05cc
DRUGEPI75 groupThe EPI75 group will receive bupivacaine 0.5% 3cc, epinephrine 1:1000 0.075cc, and sterile saline 0.025%.
DRUGEPI100 groupThe EPI100 group will receive bupivacaine 0.5% 3cc, and epinephrine 1:1000 0.1cc.

Timeline

Start date
2016-02-11
Primary completion
2016-10-20
Completion
2016-10-20
First posted
2015-12-02
Last updated
2023-06-06
Results posted
2018-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02619409. Inclusion in this directory is not an endorsement.